- Home
- GMM vs XOMAP Comparison
GMM vs XOMAP Comparison
Compare GMM & XOMAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- XOMAP
- Stock Information
- Founded
- GMM 2017
- XOMAP N/A
- Country
- GMM China
- XOMAP United States
- Employees
- GMM N/A
- XOMAP 13
- Industry
- GMM
- XOMAP Biotechnology: Pharmaceutical Preparations
- Sector
- GMM
- XOMAP Health Care
- Exchange
- GMM Nasdaq
- XOMAP Nasdaq
- Market Cap
- GMM N/A
- XOMAP N/A
- IPO Year
- GMM 2023
- XOMAP N/A
- Fundamental
- Price
- GMM $0.24
- XOMAP $25.78
- Analyst Decision
- GMM
- XOMAP
- Analyst Count
- GMM 0
- XOMAP 0
- Target Price
- GMM N/A
- XOMAP N/A
- AVG Volume (30 Days)
- GMM 9.7M
- XOMAP N/A
- Earning Date
- GMM 07-23-2024
- XOMAP N/A
- Dividend Yield
- GMM N/A
- XOMAP N/A
- EPS Growth
- GMM N/A
- XOMAP N/A
- EPS
- GMM 0.60
- XOMAP N/A
- Revenue
- GMM $33,985,284.00
- XOMAP N/A
- Revenue This Year
- GMM N/A
- XOMAP N/A
- Revenue Next Year
- GMM N/A
- XOMAP N/A
- P/E Ratio
- GMM $0.40
- XOMAP N/A
- Revenue Growth
- GMM 59.78
- XOMAP N/A
- 52 Week Low
- GMM $0.22
- XOMAP N/A
- 52 Week High
- GMM $15.40
- XOMAP N/A
- Technical
- Relative Strength Index (RSI)
- GMM 33.83
- XOMAP 46.03
- Support Level
- GMM $0.22
- XOMAP $25.69
- Resistance Level
- GMM $0.32
- XOMAP $25.98
- Average True Range (ATR)
- GMM 0.05
- XOMAP 0.13
- MACD
- GMM 0.00
- XOMAP -0.03
- Stochastic Oscillator
- GMM 9.95
- XOMAP 16.11
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.